Single-use Bioreactors Market

Single-use Bioreactors Market- By Product, type, type of cell, molecule type, application and end user

Market Synopsys

The global Single-use Bioreactors Market is valued at USD 5.31 Billion in 2024 and is projected to reach a value of USD 31.5 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 17.58% between 2025 and 2035. The revenue generated in the overall Single-use Bioreactors market can be attributed to the variation in sub-nuclear and cell assessments. The assistance and range of these bioreactors are widely used in various fields of clinical evaluation and examination. In addition, the ample demonstrations of Single-use Bioreactors gives spur to the market players. More recently, cell examination, cell culture, and single-cell evaluation have become an articulations in clinical practice. In the current situation, the advancement of the overall Single-use Bioreactors market remains uncontroversial. The rate of improvement in this market is largely determined by the new uses and limitations of clinical scientists to track things. Cell science is a huge field of application for Single-use Bioreactors.

Market Segmentation:

The Single-use Bioreactors market is segmented on the basis of product, type, type of cell, molecule type, application and end user. Based on product, the market is segmented as single use bioreactor system, single use media bags, single use filtration assembly and other products. The single use bioreactor systems segment include up to 10L, 11-100L, 101-500L, 501-1500L, and above 1500L. The single use media bags segment include 2D Bags, 3D Bags. Other products include single use vessels, tubing and connector; samplers and probes/sensor and others. By type, the market is segmented into stirred-tank SUBs, wave-induced SUBs, bubble-column SUBs, and others. By type of cell, the market is segmented into mammalian cells, bacterial cells, yeast cells and others. By molecule type, the market is segmented as monoclonal antibodies, vaccines, gene-modified cells, stem cells, others. By application, the market is segmented as research & development, process development, and bioproduction. By end user, the market is segmented as pharmaceutical & biopharmaceutical companies, CROs & CMOs and academic & research institutes.

By product, the single-use bioreactor frameworks segment represented the biggest part of the Single-use Bioreactors market in 2024.

The single-use bioreactor frameworks segment dominated the Single-use Bioreactors market in 2024. SUB frameworks offer advantages, for example, lower capital venture, lower working costs, and lower ecological impression, consequently driving the developing reception of these frameworks in biopharma applications.

By type, the blended tank SUBs portion represented the biggest portion of the Single-use Bioreactors market in 2024.

The blended tank SUBs segment accounts for highest revenue share in the Single-use Bioreactors market in 2024. The huge portion of this section can be credited to elements, for example, the high inclination for mixed tank SUBs in the development of vigorous microbial societies. Blended tank SUBs advance more noteworthy oxygen move and diminished designing difficulties like hotness evacuation, mass exchange, and higher tumult rates.

By type of cells, the mammalian cells segment embodied the major portion in the Single-use Bioreactors market in 2021.

In 2024, the mammalian cells section represented the biggest portion of the overall industry owing to expanded reception of mammalian cells because of their exceptionally motorized metabolic hardware.

{{segment_3_graph}}

By molecule type, the monoclonal antibodies segment holds the largest part of the Single-use Bioreactors market in 2024.

In 2024, the monoclonal antibodies segment represented the biggest part of the worldwide Single-use Bioreactors market. The enormous portion of this section can be ascribed to the expanding interest for SUBs in the assembling of mAbs, attributable to low speculation costs, the low necessity of the labor force, and decrease in tedious changeover methodology.

{{segment_4_graph}}

By application, the bioproduction segment portion represented the biggest portion of the Single-use Bioreactors market in 2024.

The bioproduction segment represented the largest share of the market in 2024. The enormous portion of the bioproduction section can be ascribed to the expanding application of Single-use Bioreactors in biomanufacturing and the expanding interest for SUBs in CMOs inferable from its benefits, for example, adaptability and simple scale-up.

{{segment_5_graph}}

By end user, the drug and biopharmaceutical organizations segment represented the significant share in the Single-use Bioreactors market in 2024.

The enormous portion of drug and biopharmaceutical organizations segment in this market is ascribed to expanding R&D in these organizations and the expanding creation of biologics.

{{segment_6_graph}}

In the region, North America accounted for the largest share of the Single-use Bioreactors market in 2024.

In 2024, North America holds the major share of the Single-use Bioreactors market, followed by Europe. The large share of the North America segment can be attributed to the presence of established biopharmaceutical industry and the presence of major players operating in the Single-use Bioreactors market in North America.

Competitive Landscape

The worldwide single-use bioreactor market is exceptionally cutthroat and comprises of various central parts. Organizations, as Sartorius Stedim Biotech (France), Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Eppendorf AG (Germany), Getinge AB (Sweden), Cellexus (US), CESCO Bioengineering (US), PBS Biotech Inc. (US), Distek Inc. (US), ABEC (US), G&G Technologies Inc. (US), Able Corporation & Biott Corporation (Japan), Satake Chemical Equipment Mfg., Ltd. (Japan), Solida Biotech GmBH (Germany), Stobbe Pharma GmBH (Germany), bbi-biotech GmBH (Germany), Celltainer Biotech BV (Netherlands), ENDEL ENGIE (France), Meissner Filtration Products Inc. (US), OmniBRx biotechnologies (India), GPC Bio (US), New Horizon Biotechnology Inc. (US), Cell culture company (US), and Aptus bioreactors (US), hold significant offers in the single-use bioreactor market.

Single-use Bioreactors Market is segmented as follows:

Single-use Bioreactors Market is tabulated as follows: